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Abstract
(xylyl-phanephos)Pt2+ in combination with XeF2 mediates the consecutive diastereoselective
cation-olefin cyclization/fluorination of polyene substrates. Isolated yields were typically in the
60s while enantioselectivies reached as high as 87%. The data are consistent with a stereoretentive
fluorination of a P2Pt-alkyl cation intermediate.
The fluorination of pharmaceutical drug candidates is an important strategy for masking
metabolic hot spots.1 Despite recent progress with electrophilic fluorinating reagents,2 the
synthesis of such compounds is still challenging and many deficiencies remain, especially in
the asymmetric fluorination of non-enolate-based carbon nucleophiles.3,4,5 Fluorinated
steroids (Scheme 1), in particular, are important bioactive compounds with a deficiency of
methods for their synthesis.6,7,8
De novo syntheses of carbocycles with the flexibility for F-incorporation are rare, though
such methods would considerably expand the accessibility of such privileged structures.1
Transition metal catalyzed cyclizations, if suitably coupled to M-C fluorination reactions,4
could provide a route to complex fluorinated carbo- and hetero-cycles with control of
absolute and relative stereochemistry.
Electrophilic Pt(II) complexes are effective initiators of C-C bond forming cation-olefin
cascades.9,10,11 The fate of the organometallic intermediate of these cascades can be
controlled through ligand choice, and when the supporting ligand is a diphosphine, this
intermediate is susceptible to β-H elimination and leads to net dehydrogenated products. If
this complex could instead be intercepted by a Pt-C fluorination reaction, a catalytic
cyclization/fluorination protocol would result with concomitant access to C3-fluorinated
compounds.6d The rapidity and stereospecificity with which [(triphos)Pt-R][BF4] reacts with
XeF2 to yield C-F products (Eq. 1) suggested that the desired interception might be capable
of competing with β-H elimination.12
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In the diphosphine catalyst series that we have examined, (S)-xylyl-phanephos ((S)-(–)-4,12-
bis[di(3,5-xylyl)phosphine]-[2,2]-paracyclophane) has consistently provided the highest
enantioselectivity for various cyclization chemistries. As a starting point for our catalytic
cyclization/fluorination goal, we adapted conditions previously optimized for cyclization/β-
H elimination reactions.10b The modified conditions included use of AgBF4 and NCC6F5 to
generate the “active” [(S)-(xylyl-phanephos)Pt(NCC6F5)2][(BF4)2] catalyst. Subsequent
addition of a base (to facilitate cyclization), substrate and an electrophilic fluorine source
generated the desired product (1) as a single (stereoretentive) isomer, along with variable
quantities of β-H eliminated product (3) and the Brønsted product (5) (Table 1); several
additional phosphines are included for comparison.
In screening a variety of electrophilic fluorine sources, it was discovered that only XeF2
effectively competed with β-H elimination. Other less reactive F+ sources showed
predominant to exclusive β-H elimination to 3.13 In addition to the desired 1, over
fluorination to 4 was also observed. Since controls showed that 1 does not react with XeF2
and acid is known to enhance the F+ potential of XeF2,14 we surmised that the HF byproduct
of cyclization was activating the XeF2. This problem was easily solved by the addition of
TMSOMe as an HF sponge, which additionally obviates the need for a base.15
Optimization studies included testing multiple bisphosphines, solvents, and other TMS-X
derivatives.15 Once again (S)-xylyl-phanephos was uniquely enantioselective (~75%) for
controlling the % ee of the cation-olefin cascades. Of the tested HF scavengers, TMSOMe
was the most effective inhibitor of double fluorination and like previous ionic cascades,
nitro-methane was the optimum solvent. A catalyst formulation comprised of 10 mol% (S)-
(xylyl-phanephos)PtI2, 25 mol% AgBF4, 30 mol% NCC6F5 and stoichiometric quantities of
XeF2 and TMSOMe at 0 °C provided 1 in 67% yield and with 75% enantiomeric excess.16
These optimized conditions were subsequently applied to a variety of alcohol and phenol
terminated dienes and trienes (Table 2). In most cases, high conversion of substrate occurred
within three hours, however, the reactions were allowed to proceed for 24 h at 0 °C to ensure
complete consumption of the XeF2. For the substrate classes in Table 2, no Brønsted acid
derived products like 5 were observed, and a single diastereomer consistent with
stereoretentive fluorination of the intermediate P2Pt-alkyl cation, was observed.
As shown in Table 2, variants on the phenol termini were well tolerated, except for α-
naphthol (entry 3), wherein competitive fluorination of the aryl ether product occurs even
with TMSOMe. In situ monitoring indicated that aryl fluorination occurred post cyclization /
Pt-C fluorination. In this case, extra XeF2 was used to compensate for the difluorination
stoichiometry. Unexpectedly, para-substituents improved the ee’s (entries 4–7).
Dienyl- and trienyl alcohols and phenols were also viable substrates though they behaved
peculiarly. In the case of entries 8 and 9, the yields were poor under standard conditions, but
could be recovered by exchanging TMSOMe for a polystyrene-bound piperidine base (see
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Table 1). In contrast, the triene alcohol in entry 10 performed better under the standard
conditions. These base effects are not yet understood.
In situ monitoring of a cyclization/fluorination of 2 indicated that the alkyl cation (as the
nitrile adduct, 6) serves as the catalyst resting state (31P NMR). These data support our
current view of the mechanism (Scheme 2), that has 6 competitively undergoing β-H
elimination or F+ attack to generate a [Pt]IVR(F) dication, which undergoes a stereoretentive
reductive elimination to 1. Neither the [Pt]IV nor the [Pt]-H species are observable by NMR,
however, literature precedence suggests that both routes are viable.17,5d,5f,5i,5k
In summary, we illustrate that P2Pt-dicationic catalysts can mediate the enantioselective
cation-olefin cyclization/fluorination reactions of polyprenoids to yield C3-fluorinated
carbocycles. The key feature of the putative catalytic cycle is the selective reaction of XeF2
with P2Pt-alkyl cations over P2Pt-dications, which enables the sequential cyclization/
fluorination.
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Proposed catalytic cycle for electrophilic fluorination.
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Table 2
Catalytic electrophilic fluorination.a
Entry Polyene Product Yield 1 (%ee)b Yield 3c
1 67% (75) 14%
2 67% (73) 15%
3d 49% (86) 15%e
4 56% (81) 16%
5 60% (87) 13%
6 68% (83) 24%
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Entry Polyene Product Yield 1 (%ee)b Yield 3c
7 80% (81) trace
8f 63%g 22%
9f 69% (10) 10%e
10h 56% (78) 0%
a
Condtions: 10 mol% (S)-(xylyl-phanephos)Ptl2, 25 mol% AgBF4, 30 mol% NCC6F5, 1.1 equiv TMS-OMe, 1.1 equiv XeF2, 0.4 mL CD3NO2, 0
°C, 24 h. Starting material is mass balance of reaction.
b




Reaction run using 1.6 equiv XeF2.
e
Percentage is fluorinated elimination species only
f
Reaction with 20 mol% polystyrene-bound piperidine base run, no TMS-OMe, see SI for details.
g
Due to the volatility of this compound, a GC yield is reported.
h
Contains 23% unidenfied species, mass balance is unreacted starting material. Cannot separate the unidentified species from the product, therefore
GC yield reported.
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